During the last session, Senti Biosciences Inc (NASDAQ:SNTI)’s traded shares were 0.76 million, with the beta value of the company hitting 2.24. At the end of the trading day, the stock’s price was $2.13, reflecting an intraday loss of -6.58% or -$0.15. The 52-week high for the SNTI share is $16.94, that puts it down -695.31 from that peak though still a striking 28.64% gain since the share price plummeted to a 52-week low of $1.52. The company’s market capitalization is $55.55M, and the average intraday trading volume over the past 10 days was 0.66 million shares, and the average trade volume was 173.51K shares over the past three months.
Senti Biosciences Inc (NASDAQ:SNTI) trade information
Senti Biosciences Inc (SNTI) registered a -6.58% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -6.58% in intraday trading to $2.13, hitting a weekly high. The stock’s 5-day price performance is -25.52%, and it has moved by -33.44% in 30 days. Based on these gigs, the overall price performance for the year is -10.20%. The short interest in Senti Biosciences Inc (NASDAQ:SNTI) is 0.16 million shares and it means that shorts have 4.34 day(s) to cover.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 250k as predicted by 2 analyst(s). Meanwhile, a consensus of 2 analyst(s) estimates revenue growth to 250k by the end of current fiscal year.
While earnings are projected to return 69.24% in 2025, the next five years will return 34.18% per annum.
SNTI Dividends
Senti Biosciences Inc is due to release its next quarterly earnings on 2025-Mar-20. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Senti Biosciences Inc (NASDAQ:SNTI)’s Major holders
Senti Biosciences Inc insiders own 69.35% of total outstanding shares while institutional holders control 28.21%, with the float percentage being 92.05%. NEA MANAGEMENT COMPANY, LLC is the largest shareholder of the company, while 19.0 institutions own stock in it. As of 2024-06-30, the company held over 4.43 million shares (or 9.6834% of all shares), a total value of $1.22 million in shares.
The next largest institutional holding, with 2.54 million shares, is of 8VC GP I, LLC’s that is approximately 5.5516% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $7.0 million.
